Particulars (Rupees in Crores.) | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 |
---|---|---|---|---|---|
Gross Sales | 859.63 | 786.56 | 804.93 | 693.05 | 687.76 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 859.63 | 786.56 | 804.93 | 693.05 | 687.76 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 5.95 | 15.23 | 17.66 | 84.13 | 11.41 |
Total Income | 865.59 | 801.79 | 822.59 | 777.18 | 699.18 |
Total Expenditure | 690.11 | 725.11 | 677.45 | 539.02 | 517.22 |
PBIDT | 175.48 | 76.68 | 145.14 | 238.15 | 181.96 |
Interest | 67.61 | 40.91 | 31.82 | 12.76 | 3.55 |
PBDT | 107.87 | 35.77 | 113.32 | 225.4 | 178.41 |
Depreciation | 81.24 | 69.81 | 57.46 | 38.75 | 32.28 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | 34.51 | 23.25 | 24.6 | 38.53 | 28.65 |
Deferred Tax | -15.34 | -34.44 | 0.23 | 9.51 | -2.89 |
Reported Profit After Tax | 7.45 | -22.86 | 31.04 | 138.6 | 120.36 |
Minority Interest After NP | 0.08 | 1.57 | -0.08 | -0.76 | -1.22 |
Net Profit after Minority Interest | 7.37 | -24.43 | 31.11 | 139.36 | 121.58 |
Extra-ordinary Items | 0 | 0 | 4.95 | 45.18 | 0 |
Adjusted Profit After Extra-ordinary item | 7.37 | -24.43 | 26.16 | 94.18 | 121.58 |
EPS (Unit Curr.) | 0.85 | -2.81 | 3.77 | 17.09 | 14.91 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 0 | 0 | 0 | 0 | 0 |
Equity | 8.68 | 8.68 | 8.68 | 8.15 | 8.15 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 20.41 | 9.74 | 18.03 | 34.36 | 26.45 |
PBDTM(%) | 12.54 | 4.54 | 14.07 | 32.52 | 25.94 |
PATM(%) | 0.86 | -2.9 | 3.85 | 19.99 | 17.5 |
Here are some of the stocks that may see significant price movement today: Avenue Supermarts, Bank of Baroda, HDFC Bank, etc.
According to the firm, the NDA submission package is based on three clinical trials, many pre-clinical investigations.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice